THE REPORT FROM DERMATOLOGICAL RESEARCH OF COSMETICAL PRODUCT WITH HALF OPEN PATCH TEST

Similar documents
Product Data Sheet. Manufacturer: GW Cosmetics GmbH, A-2333 Leopoldsdorf, Achauer Strasse 49a; Austria, Europe.

ENJEUX SANITAIRES ET RÉGLEMENTAIRES : FAUX PROBLÈMES ET VRAIES QUESTIONS. Françoise AUDEBERT Aurore BOUDET MOUFAREK 9 avril 2013

MATERIAL SAFETY DATA SHEET Finished Product.

FAQ. Possible Allergic Reaction

MATERIAL SAFETY DATA SHEET Finished Product. SECTION 1 CHEMICAL SUBSTANCE/PRODUCT AND COMPANY IDENTIFICATION Finished Product Name: Natural Instincts

Cosmetic Products Notification Portal (CPNP)

MATERIAL SAFETY DATA SHEET Finished Product. SECTION 1 CHEMICAL SUBSTANCE/PRODUCT AND COMPANY IDENTIFICATION Finished Product Name: Nice n Easy

Allergy skin testing (Immediate Hypersensitivity)

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

MATERIAL SAFETY DATA SHEET Finished Product.

MATERIAL SAFETY DATA SHEET Finished Product.

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

MEDICATION GUIDE Testosterone (tes-tos-te-rōn) Gel, CIII

CODEX STAN Page 1 of 5 STANDARD FOR FAT SPREADS AND BLENDED SPREADS CODEX STAN

Cosmetic products safety regulations

Public Assessment Report Scientific discussion. Tostrex (Testosterone) SE/H/571/01

NEHSNORTH EASTERN HEALTH SPECIALISTS

Topical Tacrolimus or Pimecrolimus for the treatment of mild, moderate or severe atopic eczema. Effective Shared Care Agreement

GELITA Sol C for Radiant Beauty. Comprises high-performance natural collagen peptides Provides smooth and wrinkle-free skin Repairs and protects hair

MATERIAL SAFETY DATA SHEET Finished Product.

FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)

COSMETIC PRODUCT SAFETY REPORT

Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials

CODEX STAN 168 Page 1 of 6 INTRODUCTION

Describe two factors that need to be considered when shaving

European Respiratory Society (ERS), The European Lung White Book Respiratory Health and Disease in Europe,

Procedure: Admission of products, which are not subject to authorization of the President of the Rail Transport Office, to placing in

REGULATION (EEC) No 2309/93

Survey of Chemical Substances in Consumer Products. Analysis of chemical hair-removal products. Survey no

COSMETIC PRODUCT SAFETY REPORT

DR. METIN ANTI CELULITE CREAM

TITLE: Scent Sensitivity Procedure. SPONSOR: Vice-President, Finance & Administration

LEUPHASYL A NEW PENTAPEPTIDE FOR EXPRESSION WRINKLES CODE: PD080. Date: June 2005 Revision: 1 A GMP PEPTIDE FOR COSMETIC APPLICATIONS

CLINICAL REPORT. Title of the study. Use of PSORIT-X cream shampoo in psoriasis capitis and seborrhoea capitis. Study site

BRIEFING Plastic Packaging Systems for Pharmaceutical Use.

Department of Dermatology, Churchill Hospital PUVA Treatment

TEGO Cosmo P 813 Multifunctional ingredient for deodorant applications

Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006

Allergenic Extracts: How it s Made

ZOVIRAX Cold Sore Cream

Entry 3 Award, Certificate and Diploma in Employability and Personal Development (7546) Candidate logbook

ANNEX 6 EXAMPLES OF ARRANGEMENTS

ANALYSIS OF MARKET RESEARCH DATA ON THE ICY HOT PATCH

Acetic Acid Content of Vinegar: An Acid-Base Titration E10-1

Spring water deep underground water that has been tested free of pathogens.

Course Curriculum for Master Degree in Nursing/Adult Acute Care Nursing

1. Qualitative Analysis of Chromium, Iron, and Copper

Material Safety Data Sheet Precast Agarose Gel Cassettes for the SageELF TM DNA Fractionation Instrument

Revised: 1/1/2001 N/A MSDS. Material Safety Data Sheet

FastTest. You ve read the book now test yourself

A 3-PRODUCT SALICYLIC ACID REGIMEN EFFECTIVELY TREATS ACNE VULGARIS IN POST- ADOLESCENT WOMEN

Chapter. Guaiac Screening CHAPTER 4: GUAIAC TESTING SCREENING FOR OCCULT BLOOD. Page 1 of 5 Guaiac doc 6/24/2005

Medication Guide Testim (TĔS tim) CIII (testosterone gel)

TOPICAL TREATMENTS FOR PSORIASIS

Dry skin, eczema, psoriasis and flare-ups

llergy Testing: When to test, when not to and what to do with the results

STREPSILS BLACKCURRANT FLAVOUR LOZENGES STREPSILS DRY & SORE THROAT BLACKCURRANT FLAVOUR LOZENGES

Flexagon Support Services Policy

Somulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium. Applicant: Dechra Limited

Maintenance of abstinence in alcohol dependence

Hand Dishwashing Detergents

Hand Dermatitis in Health Care Workers

MEDICATION GUIDE testosterone gel Testosterone (tes-tos-te-rone gel) CIII

How To Be A Nurse Practitioner

MACROGOL COMPOUND ORAL POWDER (sodium chloride, sodium hydrogen carbonate, potassium chloride, macrogol 3350) PL 33579/0001 UKPAR TABLE OF CONTENTS

40 YEARS OF FUN WITH CONTACT DERMATITIS IN OREGON FRANCES J. STORRS OREGON HEALTH AND SCIENCE UNIV. PORTLAND, OREGON

VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS

Official Journal of the European Union. (Acts whose publication is obligatory)

Course Curriculum for Master Degree in Nursing/ Maternal and Newborn Nursing

F r e q u e n t l y A s k e d Q u e s t i o n s

Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions

RILUZOLE LUPIN 50 MG FILM-COATED TABLETS PL 35507/0120 UKPAR TABLE OF CONTENTS

DERMATOLOGY & COSMETIC LASER CENTER

Montelukast 10mg film-coated tablets PL 17907/0474

AC Sebum Control Enzyme PF

Consent for Laser/Light Based Treatment

Hymed. Clinical Skin Care For Long Term Use

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Public Assessment Report. Decentralised Procedure

American Academy of Dermatology SHADE STRUCTURE GRANT PROGRAM

Welcome to Bella! Give the Gift of Bella. A few tips to prepare you for your first visit: Gift Certificates are just $100 for a $150 value!

ALLERGENIC EXTRACT. Prescription Set of Serial Dilutions (or Maintenance Vial (s)) INSTRUCTIONS FOR USE. U.S. Government License No.

The Cause of Acne. Caring for Acne

AC DermaPeptide Toning PF Anti-Wrinkle + Toning + Elasticity

Clinical research: where are we with the new (Paediatric) RC trial Regulation

AcneBooklet_A02.qxp :05 Side 1. Acne treatment CLINICALLY PROVEN SAFE AND EFFECTIVE

the facts about PPD (paraphenylenediamine or p-phenylenediamine) is an ingredient used in permanent (also known as oxida ve) hair colorants.

RE: Youth Challenge International Medical Form. Dear Doctor:

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark

GUIDELINES FOR IMPORT AND MANUFACTURE OF MEDICAL DEVICES

Product Bulletin INTEROX HYDROGEN PEROXIDE

CONSUMERS, COSMETICS AND SKIN SENSITIZERS

Consumer guide How you can learn more to be better prepared.

GUIDELINE ON THE CONTROL OF COSMETIC PRODUCTS

Ha-Lactase 5200 Product Information

You can paint polish over your NSI nails. However, always use a NON-Acetone based nail polish remover.

RE: NDA: DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER

Transcription:

B (97/02/2016) THE REPORT FROM DERMATOLOGICAL RESEARCH OF COSMETICAL PRODUCT WITH HALF OPEN PATCH TEST Product Biobellinda Permanent Hair Dye Cream 8.0 Light Auburn Biobellinda Kalıcı Krem Saç Boyası 8.0 Açık Kumral Responsible Person Biobellinda Kozmetik Ve Temizlik Ürünleri Pazarlama A.Ş. Report number B-0181/16 Issue date 14.03.2016

Table of contents Table of contents... 2 1. RESEARCH BASIS... 3 2. PRODUCT CHARACTERISTIC... 3 3. METHODOLOGY... 3 4. THE AIM OF STUDY... 4 5. SUBJECT VOLUNTEERS SELECTION... 4 6. RESULTS... 4 7. CONCLUSION... 5 2/5

1. RESEARCH BASIS Order date 25.02.2016 Order number 97/02/2016 Research time frame 29.02.2016 11.03.2016 Report issue date 14.03.2016 CUSTOMER NAME Pim Eğitim ve Danişmanlik Hizmetleri, Göktürk Cad. Suvenue Sitesi B Blok Kat:3 D:7 Eyüp-İstanbul RESPONSIBLE PERSON NAME Company name Biobellinda Kozmetik Ve Temizlik Ürünleri Pazarlama A.Ş. Address Product name Ingredients Biobellinda Permanent Hair Dye Cream 8.0 Light Auburn Biobellinda Kalıcı Krem Saç Boyası 8.0 Açık Kumral Aqua/Water, Cetearyl Alcohol, Ethanolamine, Cetearath-20, Propylene Glycol, Resorcinol, p-phenylenediamine, m-aminophenol, Phenyl Methyl Pyrazolone, 2-metylresorcınol, p-aminophenol, 4-Amino-2-Hydroxytoluene, Prunus Amygdalus Dulcis Oil, Sodium Sulfite, Ascorbic Acid, Disodium EDTA 3/5 2. PRODUCT CHARACTERISTIC Product Package Product Appearance Product purpose Supplementary white, plastic bottle and white metal tube labeled with product s name White cream and yellow gel with specific scent Hair dye The responsible person is responsible for conformity with declared qualitative and quantitative composition and microbiological purity of the delivered research samples. 3. METHODOLOGY The study was conducted in accordance with Regulation of the European Parliament and Council Regulation (EC) No 1223/2009 of 30 November 2009 on cosmetic. The study was conducted in accordance with recommendation of Cosmetics Europe The Personal Care Association Guidelines: product test guidelines for the Assessment of Human Skin Compatibility 1997 guidelines for the evaluation of the Efficacy of Cosmetic Products 2008. Patch tests according to Jadassohn-Bloch with Rudzki modifications were conducted under careful supervise of medical specialists dermatologists. The assessment of the allergenic and irritant features was made on a group of 30 healthy volunteers no allergological history, familiarized with contraindications and recommendations for the study /not currently taking any medication that may have any effect on the result of the test/, familiarized with contraindications and recommendations for the study. The probands selection, samples application and reading took place in Diagnostic Test in Bialystok. The tested preparation in a commercial formulation is applied to chamber cell-petal patches of Finn Chamber which are put around a vane. Patches are

removed after 48 hours and the first reading is conducted. Another reading takes place 72 hours after insertion of the sample. A dermatologist based on the observations of skin reactions evaluates allergenic action of the conducted substance. Positive reaction (erythema) confirms allergenic properties of the formulation, negative reaction (no erythema) confirms the absence of allergenic properties of the formulation. 4. THE AIM OF STUDY The aim is to assess irritating and allergenic properties of the product in a healthy adult volunteer by single insert of patch test and the reading of skin reaction after 48 and 72 hours. 5. SUBJECT VOLUNTEERS SELECTION The selection of probands volunteers was conducted by a dermatologist according to the Declaration of Helsinki of 1964 (with subsequent amendments), Polish laws, Cosmetics Europe directives with applying inclusion and exclusion criteria. 30 people took part in the study at the age of 22-59 years old: 17 women and 13 men who met the requirements for entering the study and agreed to informed consent to participate in the study. The skin at the selected area was normal, without any lesions. Subjects were informed not to use any kinds of antihistamines or pharmacological agents at the time of test, which may affect the tests results. 6. RESULTS Subject Age Sex Erythema Oedema Scaling Subject Age Sex Erythema Oedema Scaling 1 57 F (0) (0) (0) 16 23 F (0) (0) (0) 2 22 F (0) (0) (0) 17 28 M (0) (0) (0) 3 52 M (0) (0) (0) 18 35 F (0) (0) (0) 4 36 F (0) (0) (0) 19 38 F (0) (0) (0) 5 40 M (0) (0) (0) 20 44 M (0) (0) (0) 6 32 F (0) (0) (0) 21 47 M (0) (0) (0) 7 38 M (0) (0) (0) 22 39 F (0) (0) (0) 8 57 F (0) (0) (0) 23 25 F (0) (0) (0) 9 26 F (0) (0) (0) 24 55 M (0) (0) (0) 10 33 M (0) (0) (0) 25 59 F (0) (0) (0) 11 41 F (0) (0) (0) 26 46 M (0) (0) (0) 12 38 M (0) (0) (0) 27 32 F (0) (0) (0) 13 28 M (0) (0) (0) 28 23 F (0) (0) (0) 14 33 M (0) (0) (0) 29 25 F (0) (0) (0) 15 45 F (0) (0) (0) 30 40 M (0) (0) (0) Legend: E (erythema) - (0) zero; (1) weak; (2) moderate; (3) strong; (4) very strong O (oedema) - (0) zero; (1) weak; (2) moderate; (3) strong; (4) very strong S (scaling) - (0) zero; (1) weak; (2) moderate; (3) strong; (4) very strong (-) negative result, (?) questionable result M man, F woman 4/5

RESULTS: In 30 subjects, the results of patch tests were negative, which means that the product does not cause irritation or allergy reaction in those subjects. 7. CONCLUSION 1. Having conducted patch tests, one may state that the cosmetic product Biobellinda Permanent Hair Dye Cream 8.0 Light Auburn/ Biobellinda Kalıcı Krem Saç Boyası 8.0 Açık Kumral does not have irritant or allergenic action. 2. The issued opinion does not apply to anybody with an allergy to any of the ingredients of the tested preparation. 3. The issued opinion does not include analysis of the composition of the product. 4. The tested preparation fulfills requirements for cosmetic products of declared specification, in regards to human health safety. Stamp and Signature of investigator Adam A. Wroński MD. PhD. Aleksander Wroński MD. PhD 1. The report may be reproduced only in its entirety. Another form of copying requires the written consent of the Contractor. 2. Report from research carried out in two identical copies (copy 1 Customer, copy 2 Diagnostic-Test). 3. The results refer only to the product of the composition given by the Principal. 5/5